TCF National Bank’s Gilead Sciences GILD Stock Holding History

TCF National Bank’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$880K	Sell	13,605 -3,832	-22%	-$247K	0.1%	198
2020 Q4	$1.02M	Buy	17,437 +192	+1%	+$11.6K	0.11%	186
2020 Q3	$1.09M	Sell	17,245 -3,764	-18%	-$261K	0.13%	168
2020 Q2	$1.42M	Buy	21,009 +3,022	+17%	+$232K	0.16%	141
2020 Q1	$1.34M	Buy	17,987 +153	+0.9%	+$10.6K	0.2%	118
2019 Q4	$1.16M	Sell	17,834 -1,450	-8%	-$94.4K	0.13%	168
2019 Q3	$1.22M	Buy	+19,284	New	+$1.26M	0.15%	161

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

TCF National Bank's GILD Position: Q1 2021 in Review

TCF National Bank reduced its Gilead Sciences (GILD) stake by 22% in Q1 2021, selling an estimated $247K and leaving 13,605 shares worth $880K. The position accounts for 0.1% of the portfolio, ranked #198.

TCF National Bank first reported a position in GILD in Q3 2019 and has held it in 7 quarters since. The position peaked at $1.42M in Q2 2020. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

TCF National Bank held 13,605 shares of Gilead Sciences worth $880K as of Q1 2021.
TCF National Bank sold 3,832 Gilead Sciences shares in Q1 2021, an estimated $247K.
Gilead Sciences made up 0.1% of TCF National Bank's portfolio in Q1 2021, its #198 holding.
TCF National Bank first reported a position in Gilead Sciences in Q3 2019 and has held it in 7 quarters since.
TCF National Bank's Gilead Sciences position peaked at $1.42M in Q2 2020.
1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on TCF National Bank's 13F filing for Q1 2021, filed 30 Apr 2021.